Active, Not Recruiting
Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD
NCT04023552
- Conditions
- Brain Diseases, Cardiovascular Disease and Lipoprotein(a), Cardiovascular Diseases, +13 more
- Locations
-
- SEC Clinical Research LLC Andalusia, Alabama, United States
- Grandview Med Group Research LLC Birmingham, Alabama, United States
- Novartis Investigative Site Birmingham, Alabama, United States
- Heart Center Research Llc Huntsville, Alabama, United States